Merit Medical Systems Inc

Most Recent

  • uploads///Interventional Solutions
    Company & Industry Overviews

    Johnson & Johnson’s Interventional Solutions Business

    JNJ’s Interventional Solutions segment generated third-quarter net revenues of $653.0 million, compared to $553.0 million in the third quarter of 2017.

    By Daniel Collins
  • uploads///blood _
    Company & Industry Overviews

    What Analysts Recommend for Edwards Lifesciences

    Of the 22 analysts covering Edwards Lifesciences in February 2018, 17 analysts have given the stock a “buy” or a higher rating.

    By Kenneth Smith
  • uploads///EW revenue
    Company & Industry Overviews

    Analyzing Edwards Lifesciences’ Recent Acquisitions

    In December 2017, Edwards Lifesciences (EW) acquired Harpoon Medical for a total consideration of $119.5 million.

    By Kenneth Smith
  • uploads///MMSI revenue
    Company & Industry Overviews

    Exploring Merit Medical Systems’ Business Segments

    In 3Q17, Merit Medical Systems’ cardiovascular segment generated revenues of $172.7 million—compared to $150.5 million in 3Q16.

    By Kenneth Smith
  • uploads///doctors office checkup medical
    Company & Industry Overviews

    Merit Medical Systems: Analysts’ Ratings in February 2018

    Of the eight analysts covering Merit Medical Systems in February, four gave it a “strong buy,” three gave it a “buy,” and one gave it a “sell” rating.

    By Kenneth Smith
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.